Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.1 USD | +4.03% |
|
+17.90% | +135.88% |
Jul. 10 | Goldman Sachs Raises Price Target on Insmed to $102 From $74, Maintains Buy Rating | MT |
Jul. 09 | Guggenheim Adjusts Price Target on Insmed to $95 From $70, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+135.88% | 11.79B | |
+20.82% | 127B | |
+21.96% | 116B | |
+23.17% | 27.69B | |
-22.97% | 19.62B | |
-17.08% | 16.26B | |
-19.03% | 15.49B | |
+11.66% | 14.81B | |
-48.41% | 14.39B | |
+54.78% | 14.11B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- Sector Update: Health Care